229 related articles for article (PubMed ID: 15947124)
21. 5-HT3 receptor antagonists vs traditional agents for the prophylaxis of postoperative nausea and vomiting.
Loewen PS; Marra CA; Zed PJ
Can J Anaesth; 2000 Oct; 47(10):1008-18. PubMed ID: 11032279
[TBL] [Abstract][Full Text] [Related]
22. Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as at high risk for developing PONV.
Pellegrini J; DeLoge J; Bennett J; Kelly J
AANA J; 2009 Aug; 77(4):293-9. PubMed ID: 19731848
[TBL] [Abstract][Full Text] [Related]
23. [Postoperative nausea and vomiting in adult patients].
Pierre S; Corno G
Ann Fr Anesth Reanim; 2003 Feb; 22(2):119-29. PubMed ID: 12706765
[TBL] [Abstract][Full Text] [Related]
24. [Influence of dexamethasone on the incidence of postoperative nausea and vomiting in breast cancer patients with neoadjuvant chemotherapy].
Li ZH; Liu D; He ZJ; Fan ZY
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):685-9. PubMed ID: 26284410
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies.
Kovac AL
Ann Pharmacother; 2006 May; 40(5):873-87. PubMed ID: 16670361
[TBL] [Abstract][Full Text] [Related]
26. [A factorial trial of six interventions for the prevention of postoperative nausea and vomiting].
Apfel CC; Bacher A; Biedler A; Danner K; Danzeisen O; Eberhart LH; Forst H; Fritz G; Hergert M; Frings G; Goebel A; Hopf HB; Kerger H; Kranke P; Lange M; Mertzlufft F; Motsch J; Paura A; Roewer N; Schneider E; Stoecklein K; Wermelt J; Zernak C
Anaesthesist; 2005 Mar; 54(3):201-9. PubMed ID: 15731931
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of prophylactic dolasetron or droperidol vs rescue therapy in the prevention of PONV in ambulatory gynecologic surgery.
Frighetto L; Loewen PS; Dolman J; Marra CA
Can J Anaesth; 1999 Jun; 46(6):536-43. PubMed ID: 10391600
[TBL] [Abstract][Full Text] [Related]
28. Management strategies for the treatment and prevention of postoperative/postdischarge nausea and vomiting: an updated review.
Elvir-Lazo OL; White PF; Yumul R; Cruz Eng H
F1000Res; 2020; 9():. PubMed ID: 32913634
[TBL] [Abstract][Full Text] [Related]
29. [Postoperative nausea and vomiting: cost and therapeutic algorithm. Part II: high-risk patients and late PONV].
Odin I; Merle JC; Feiss P; Nathan N
Ann Fr Anesth Reanim; 2004 Jun; 23(6):581-8. PubMed ID: 15234723
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic options for the prevention and treatment of postoperative nausea and vomiting: a pharmacoeconomic review.
Lachaine J
Pharmacoeconomics; 2006; 24(10):955-70. PubMed ID: 17002479
[TBL] [Abstract][Full Text] [Related]
31. Impact of a prophylactic combination of dexamethasone-ondansetron on postoperative nausea and vomiting in obese adult patients undergoing laparoscopic sleeve gastrectomy during closed-loop propofol-remifentanil anaesthesia: A randomised double-blind placebo-controlled study.
Bataille A; Letourneulx JF; Charmeau A; Lemedioni P; Léger P; Chazot T; Le Guen M; Diemunsch P; Fischler M; Liu N
Eur J Anaesthesiol; 2016 Dec; 33(12):898-905. PubMed ID: 26866433
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.
Singh PM; Borle A; Gouda D; Makkar JK; Arora MK; Trikha A; Sinha A; Goudra B
J Clin Anesth; 2016 Nov; 34():459-82. PubMed ID: 27687434
[TBL] [Abstract][Full Text] [Related]
33. The impact of current antiemetic practices on patient outcomes: a prospective study on high-risk patients.
White PF; O'Hara JF; Roberson CR; Wender RH; Candiotti KA;
Anesth Analg; 2008 Aug; 107(2):452-8. PubMed ID: 18633023
[TBL] [Abstract][Full Text] [Related]
34. Use of a disposable acupressure device as part of a multimodal antiemetic strategy for reducing postoperative nausea and vomiting.
White PF; Zhao M; Tang J; Wender RH; Yumul R; Sloninsky AV; Naruse R; Kariger R; Cunneen S
Anesth Analg; 2012 Jul; 115(1):31-7. PubMed ID: 22504214
[TBL] [Abstract][Full Text] [Related]
35. What is new in the battle against postoperative nausea and vomiting?
Tateosian VS; Champagne K; Gan TJ
Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):137-148. PubMed ID: 30322455
[TBL] [Abstract][Full Text] [Related]
36. [Postoperative nausea and vomiting: rational algorithms for prevention and treatment based on current evidence].
Kranke P; Eberhart LH
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Apr; 44(4):286-94; quiz 295. PubMed ID: 19367533
[TBL] [Abstract][Full Text] [Related]
37. [Metoclopramide and dexamethasone in prevention of postoperative nausea and vomiting after inhalational anaesthesia].
Wallenborn J; Rudolph C; Gelbrich G; Goerlich TM; Döhnert J; Dörner J; Olthoff D
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Nov; 38(11):695-704. PubMed ID: 14600859
[TBL] [Abstract][Full Text] [Related]
38. A network meta-analysis on the efficacy of serotonin type 3 receptor antagonists used in adults during the first 24 hours for postoperative nausea and vomiting prophylaxis.
Tang DH; Malone DC
Clin Ther; 2012 Feb; 34(2):282-94. PubMed ID: 22296947
[TBL] [Abstract][Full Text] [Related]
39. Inspired oxygen fraction of 0.8 compared with 0.4 does not further reduce postoperative nausea and vomiting in dolasetron-treated patients undergoing laparoscopic cholecystectomy.
Piper SN; Röhm KD; Boldt J; Faust KL; Maleck WH; Kranke P; Suttner SW
Br J Anaesth; 2006 Nov; 97(5):647-53. PubMed ID: 16963789
[TBL] [Abstract][Full Text] [Related]
40. A risk adapted approach reduces the overall institutional incidence of postoperative nausea and vomiting.
Biedler A; Wermelt J; Kunitz O; Müller A; Wilhelm W; Dethling J; Apfel CC
Can J Anaesth; 2004 Jan; 51(1):13-9. PubMed ID: 14709454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
